| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.057 | 0.4 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.053 | 0.4 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.4 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |